Civic AI
Procurement intelligence
Federal contract award
8511856699!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC. · Department of Defense
- Value
- $3,950,554
- Start
- Jan 13, 2026
- End
- Jan 27, 2026
- Action date
- Jan 13, 2026
- PIID
- SPE2DP26F1649
- Status
- completed
- NAICS
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- Place of performance
- PARSIPPANY, NJ
- Award type
- DELIVERY ORDER
Description
8511856699!ADENOVIRUS TYPE 4 A
Need modifications, related awards, and vendor peers? Open the full award workspace.